Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carbohydrates in transplantation.

X Chen1, P R Andreana, P G Wang

  • 1Department of Chemistry, Wayne State University, Detroit, MI 48202, USA.

Current Opinion in Chemical Biology
|December 22, 1999
PubMed
Summary

Carbohydrate materials, specifically alpha-galactosyl epitopes, are crucial in preventing hyperacute rejection in xenotransplantation. Alpha-galactosyl polymers show significantly higher efficacy than monomers in inhibiting antibody binding and preventing cell damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Investigation and factor analysis of postoperative surgical site infections in emergency abdominal surgery in China from 2018 to 2021 based on Chinese SSI Surveillance].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery·2023
Same author

[Establishment and validation of a predictive clinical model for postoperative surgical site infection in patients with colorectal surgery].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery·2023
Same author

[Surgical site infection after colorectal surgery in China from 2018 to 2020].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery·2022
Same author

COVID-19 prevention measures reduce dengue spread in Yunnan Province, China, but do not reduce established outbreak.

Emerging microbes & infections·2021
Same author

Synthesis of glycoimmunogen Tn-Thr-PS A1 <i>via</i> hydrazone bond and stability optimization of PS A1 monosaccharide mimics under vaccine development conditions.

Journal of carbohydrate chemistry·2021
Same author

[Progress in the treatment of intra-abdominal anaerobic infection].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery·2020

Area of Science:

  • Biomaterials Science
  • Immunology
  • Transplantation Biology

Background:

  • Carbohydrate materials are gaining prominence in transplantation and tissue engineering.
  • Alpha-galactosyl epitopes, characterized by the Galalpha1-3Gal sequence, are key in xenotransplantation research.
  • Preventing hyperacute rejection is a critical challenge in xenotransplantation.

Purpose of the Study:

  • To evaluate the efficacy of alpha-galactosyl epitopes in preventing hyperacute rejection.
  • To compare the activity of alpha-galactosyl polymers and monomers in inhibiting anti-galactosyl antibody binding.
  • To assess the role of these carbohydrate materials in preventing xenograft cytotoxicity.

Main Methods:

  • Application of immobilized or soluble alpha-galactosyl epitopes in pig-to-primate xenotransplantation models.

Related Experiment Videos

  • In vitro assays measuring the inhibition of anti-galactosyl antibody binding to pig kidney epithelial cells.
  • Assessment of cytotoxicity in human serum exposure.

    • Main Results:

    • Alpha-galactosyl epitopes have demonstrated effectiveness in preventing hyperacute rejection.
    • Alpha-galactosyl polymers exhibited up to 10,000 times greater activity than monomers.
    • Polymers significantly inhibited antibody binding and reduced cytotoxicity.

    Conclusions:

    • Alpha-galactosyl polymers represent a highly effective strategy for mitigating immune rejection in xenotransplantation.
    • These carbohydrate-based materials hold significant potential for advancing cell and tissue engineering applications.
    • Further research into carbohydrate materials can improve xenograft survival and clinical outcomes.